Evidence map›Paper›PMID 31409778›Full record

ArticleNature communications2019

Cellular internalization of bystander nanomaterial induced by TAT-nanoparticles and regulated by extracellular cysteine.

Yushuang Wei, Tang Tang, Hong-Bo Pang

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Nanomaterial Probes for Nuclear Imaging.Nanomaterials (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yushuang WeiDepartment of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.
Tang TangDepartment of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.
Hong-Bo PangDepartment of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA. pang0051@umn.edu.ORCID http://orcid.org/0000-0002-2054-7711

Funding

Improving the in Vivo Delivery and Antitumor Efficacy of Antisense DrugsR01CA214550 · NCI · UNIVERSITY OF MINNESOTA · PI PANG, HONGBO · 2017 to 2021
$1.7M
Deciphering the nanomaterial uptake in a bystander manner invoked by co-administration of functionalized nanoparticlesR01GM133885 · NIGMS · UNIVERSITY OF MINNESOTA · PI PANG, HONGBO · 2019 to 2022
$1.2M
Decoding the macropinocytic machinery for intracellular delivery of nanomaterialsR21EB022652 · NIBIB · UNIVERSITY OF MINNESOTA · PI PANG, HONGBO · 2016 to 2017
$498k
NCI NIH HHS R01 CA214550NIBIB NIH HHS R21 EB022652NIGMS NIH HHS R01 GM133885
6 · The paper itself

Abstract

Entry into cells is necessary for many nanomaterial applications, and a common solution is to functionalize nanoparticles (NPs) with cell-penetrating ligands. Despite intensive studies on these functionalized NPs, little is known about their effect on cellular activities to engulf other cargo from the nearby environment. Here, we use NPs functionalized with TAT (transactivator of transcription) peptide (T-NPs) as an example to investigate their impact on cellular uptake of bystander cargo. We find that T-NP internalization enables cellular uptake of bystander NPs, but not common fluid markers, through a receptor-dependent macropinocytosis pathway. Moreover, the activity of this bystander uptake is stimulated by cysteine presence in the surrounding solution. The cargo selectivity and cysteine regulation are further demonstrated ex vivo and in vivo. These findings reveal another mechanism for NP entry into cells and open up an avenue of studying the interplay among endocytosis, amino acids, and nanomaterial delivery.

Indexed as

Biological TransportCell LineCysteineEndocytosisHumansLigandsNanoparticlesTrans-ActivatorsCysteineLigandsTrans-Activators

Identifiers

PMID31409778
PMCPMC6692393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.